Karuna Therapeutics Inc (NASDAQ:KRTX)
| 223.40 Delayed Data As of 3:59pm ET |  -7.55 / -3.27%Today’s Change | 92.26 Today|||52-Week Range 278.25 | +70.53% Year-to-Date |
Latest KRTX News | Press Releases
| Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? Nov 23 / Zacks.com - Paid Partner Content | My 3 Top Biotech Stock Picks for 2023 Nov 22 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 230.95 |
| Today’s open | 231.30 |
| Day’s range | 223.26 - 231.30 |
| Volume | 5,414 |
| Average volume (3 months) | 468,418 |
| Market cap | $7.9B |
Data as of 3:59pm ET, 11/28/2022
Growth & Valuation
| Earnings growth (last year) | -90.39% |
| Earnings growth (this year) | -77.36% |
| Earnings growth (next 5 years) | -18.16% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 103.27 |
| Price/Book | 13.57 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CTLTCatalent Inc | +5.52 | +13.34% |
| ---- | ||
| RDYDr Reddy's Laborator... | -0.14 | -0.26% |
| ---- |
Data as of 4:00pm ET, 11/28/2022
Financials
| Next reporting date | February 16, 2023 |
| EPS forecast (this quarter) | -$2.24 |
| Annual revenue (last year) | $37.0M |
| Annual profit (last year) | -$143.8M |
| Net profit margin | -389.04% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Boston, Massachusetts |
Forecasts
